Raymond James Financial Services Advisors Inc. Increases Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Raymond James Financial Services Advisors Inc. boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 8.9% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 153,692 shares of the financial services provider’s stock after purchasing an additional 12,611 shares during the quarter. Raymond James Financial Services Advisors Inc. owned about 0.27% of iShares Biotechnology ETF worth $20,879,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Glass Jacobson Investment Advisors llc raised its position in shares of iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after buying an additional 122 shares in the last quarter. PCA Investment Advisory Services Inc. purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $28,000. Horizon Bancorp Inc. IN purchased a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at about $44,000. Massmutual Trust Co. FSB ADV raised its position in shares of iShares Biotechnology ETF by 164.2% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock valued at $49,000 after buying an additional 225 shares in the last quarter. Finally, CVA Family Office LLC purchased a new stake in shares of iShares Biotechnology ETF during the 4th quarter valued at about $51,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.22 on Friday. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16. The company’s 50-day moving average is $136.48 and its 200 day moving average is $128.81.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a $0.126 dividend. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date of this dividend was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.